[1] DU-BOIS R M.Strategies for treating idiopathic pulmonary fibrosis[J].Nat Rev Drug Discov,2010,9(2):129-140.
[2] FABIAN M R,SONENBERG N,FILIPOWICZ W.Regulation of mRNA translation and stability by microRNAs[J].Annu Rev Biochem,2010,79(1):351-379.
[3] 徐晓峰,周怀君.miRNA30c的研究进展[J].东南大学学报:医学版,2011,30(3):514-518.
[4] 张佳菊,冯毅,王莉娜.循环miRNA与心血管疾病研究进展[J].东南大学学报:医学版,2013,32(4):461-465.
[5] VENTURA A,JACKS T.MicroRNAs and cancer:short RNAs go a long way[J].Cell,2009,136(4):586-591.
[6] MOROZOVA O,MARRA M A.Applications of next-generation sequencing technologies in functional genomics[J].Genomics,2008,92(5):255-264.
[7] 刘潜,付洁,宋海峰.微小RNA分析技术研究进展[J].生物技术通讯,2013:24(5):710-714.
[8] ALLAWI H T,DAHLBERG J E,OLSON S,et al.Quantitation of microRNAs using a modified invader assay[J].RNA,2004,10(7):1153-1161.
[9] 景花,宋沁馨,周国华.MicroRNA定量检测方法的研究进展[J].遗传,2010,32(1):31-40.
[10] FANG S,LEE H J,WARK A W,et al.Attomole microarray detection of microRNAs by nanoparticle-amplified SPR imaging measurements of surface polyadenylation reactions[J].J Am Chem Soc,2006,128(43):14044-14046.
[11] NEELY L A,PATEL S,GARVER J,et al.A single-molecule method for the quantitation of microRNA gene expression[J].Nat Methods,2006,3(1):41-46.
[12] van ROOIJ E,SUTHERLAND L B,THATCHER J E,et al.Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J].Proc Natl Acad Sci USA,2008,105(35):13027-13032.
[13] HE Y,HUANG C,LIN X,et al.MicroRNA-29 family,a crucial therapeutic target for fibrosis diseases[J].Biochimie,2013,95(7):1355-1359.
[14] CUSHING L,KUANG P P,QIAN J,et al.MiR-29 is a major regulator of genes associated with pulmonary fibrosis[J].Am J Respir Cell Mol Biol,2010,45(2):287-294.
[15] JUN X,XIAO M M,XIAO R H,et al.MiR-29 inhibits bleomycin-induced pulmonary fibrosis in mice[J].Mol Ther,2012,20(6):1251-1260.
[16] LIU G,FRIGGERI A,YANG Y,et al.MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis[J].J Exp Med,2010,207(8):1589-1597.
[17] MARTIN M M,LEE E J,BUCKENBERGER J A,et al.MicroRNA-155 regulates human angiotensin Ⅱ type 1 receptor expression in fibroblasts[J].J Biol Chem,2006,281(27):18277-18284.
[18] KONIGSHOFF M,WILHELM A,JAHN A,et al.The angiotensin II receptor 2 is expressed and mediates angiotensin Ⅱ signaling in lung fibrosis[J].Am J Respir Cell Mol Biol,2007,37(6):640-650.
[19] MARSHALL R P,GOHLKE P,CHAMBERS R C,et al.Angiotensin II and the fibroproliferative response to acute lung injury[J].Am J Physiol Lung Cell Mol Physiol,2004,286(1):L156-164.
[20] POTTIER N,MAURIN T,CHEVALIER B,et al.Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts:implication in epithelial-mesenchymal interactions[J].PLoS One,2009,4(8):e6718.
[21] KUSUM V P,JADRANKA M,NAFTALI K.MicroRNAs in idiopathic pulmonary fibrosis[J].Transl Res,2011,157(4):191-199.
[22] WONG T S,LIU X B,WONG B Y,et al.Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue[J].Clin Cancer Res,2008,14(9):2588-2592.
[23] LIU H,BRANNON A R,REDDY A R,et al.Identifying mRNA targets of microRNA dysregulated in cancer:with application to clear cell renal cell carcinoma[J].BMC Syst Biol,2010,4:51.
[24] LUO Z,ZHANG L,LI Z,et al.MiR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells[J].Zhong Nan Da Xue Xue Bao Yi Xue Ban,2011,36(7):604-609.
[25] LUO Z,ZHANG L,LI Z,et al.An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma[J].BMC Med Genomics,2012,5:3.
[26] WANG M L,YE Y,QIAN H Y,et al.Common genetic variants in pre-microRNAs are associated with risk of coal workers'pneumoconiosis[J].J Hum Genet,2010,55(1):13-17.
[27] 王莎莎.miR-149调控矽尘诱导肺纤维化的初步研究.江苏:南京医科大学,2012.
[28] PANDIT K V,CORCORAN D,YOUSEF H,et al.Inhibition and role of let-7d in idiopathic pulmonary fibrosis[J].Am J Respir Crit Care Med,2010,182(2):220-229.
[29] MAYR C,HEMANN M T,BARTEL D P.Disrupting the pairing between let-7 and HMGA2 enhances oncogenic transformation[J].Science,2007,315(5818):1576-1579.
[30] THUAULT S,VALCOURT U,PETERSEN M,et al.Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition[J].J Cell Biol,2006,174(2):175-183.
[31] GREGORY P A,BERT A G,PATERSON E L,et al.The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1[J].Nat Cell Biol,2008,10(5):593-601.
[32] YANG S,BANERJEE S,de FREITAS A,et al.Participation of miR-200 in pulmonary fibrosis[J].Am J Pathol,2012,180(2):484-493.
[33] CARUSO P,MACLEAN M R,KHANIN R,et al.Dynamic changes in lung microRNA profiles during the development of pulmonary hy-pertension due to chronic hypoxia and monocrotalin[J].Arterioscler Thromb Vasc Biol,2010,30(4):716-723.
[34] OGLESBY I K,BRAY I M,CHOTIRMALL S H,et al.MiR-126 is down-regulated in cystic fibrosis airw ay epithelial cells and regulates TOM1 expression[J].J Immunol,2010,184(4):1702-1709.
[35] DAKHLALLAH D,BATTE K,WANG Y,et al.Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis[J].Am J Respir Crit Care Med,2013,187(4):397-405.
[36] MILOSEVIC J,PANDIT K,MAGISTER M,et al.Profibrotic role of miR-154 in pulmonary fibrosis[J].Am J Respir Cell Mol Biol,2012,47(6):879-887.
[37] CALIN G A,CROCE C M.MicroRNA-cancer connection:the beginning of a new tale[J].Cancer Res,2006,66(15):7390-7394.
[38] KENT O A,MENDELL J T.A small piece in the cancer puzzle:microRNAs as tumor suppressors and oncogenes[J].Oncogene,2006,25(46):6188-6196.
[39] PFEFFER S,VOINNET O.Viruses,microRNAs and cancer[J].Oncogene,2006,25(46):6211-6219.
[40] BADER A G,BROWN D,WINKLER M.The promise of microRNA replacement therapy[J].Cancer Res,2010,70(18):7027-7030.
[41] ZHANG X Y,SHIMURA S,MASUDA T,et al.Antisense oligonucleotides to NF-kappa B improve survival in bleomycin-induced pneumopathy of the mouse[J].Am J Respir Crit Care Med,2000,162(4 Pt 1):1561-1568.
[42] 张迎建,李文超,杨红.microRNA在预防医学中的研究进展[J].东南大学学报:医学版,2013,32(5):606-611. |
